Using Artificial Intelligence to Reduce the Risk of Nonadherence in Patients on Anticoagulation Therapy
Stroke 48:1416-1419, Labovitz, D.L.,et al, 2017
Is Prophylactic Anticoagulation for Deep Venous Thrombosis Common Practice after Intracerebral Hemorrhage?
Stroke 46:369-375, Prabhakaran, S.,et al, 2015
Relapse in Multiple Sclerosis
BMJ 350:h1765, Galea, I.,et al, 2015
Dietary Treatment in Adults with Refractory Epilepsy
Neurol 83:1978-1985, Klein, P.,et al, 2014
Using Dabigatran in Patients with Stroke A Practical Guide for Clinicians
Stroke 43:271-279, Alberts, M.J.,et al, 2012
Increased Risk of Stroke After Discontinuation of Acetlysalicylic Acid: A UK Primary Care Study
Neurol 76:740-746, Rodr�guez,L.A.G.,et al, 2011
Withdrawal of Antithrombotic Agents and Its Impact on Ischemic Stroke Occurence
Stroke 42:2509-2514, Broderick, J.,et al, 2011
Barriers to the Use of Anticoagulation for Nonvalvular Atrial Fibrillation: A Representative Survey of Australian Family Physicians
Stroke 39:227-230,7, Gattellari,M.,et al, 2008
Syncope, Driving Recommendations, and Clinical Reality: Survey of Patients
BMJ 326:21, Maas,R.,et al, 2003
Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management
The Neurologist 8:227-236, Frohman,E.,et al, 2002
Compliance With Secondary Prevention of Ischemic Stroke
Stroke 32:1884-1889, Sappok,T.,et al, 2001
Anticoagulant Patient Information Material Is Written at High Readability Levels
Stroke 31:2966-2970, Estrada,C.A.,et al, 2000
Patients with Refractory Seizures
NEJM 340:1565-1570, Devinsky,O, 1999
Long-Term Therapeutic Management of Epilepsy
Ann Int Med 120:411-422, French,J., 1994
Compliance with Antiplatelet Therapy in Pts with Ischemic CVD:Assessment by Platelet Aggregation Testing
Stroke 25:2337-2342, Komiya,T.,et al, 1994
Etiology and Mortality of Status Epilepticus in Children, A Recent Update
Arch Neurol 46:74-76, Phillips,S.A.&Shanahan,R.J., 1989